Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
October 16, 2025
Approximately 5 minutes
Medical Device Classification: TGA Risk-Based System
Australian Medical Device Classification: TGA Risk-Based System
The Therapeutic Goods Administration (TGA) in Australia classifies medical devices based on their potential risk to the patient and user. This risk-based classification system, which includes Class I, IIa, IIb, III, and Active Implantable Medical Devices (AIMD), is foundational, as it dictates the level of regulatory scrutiny, the required Conformity Assessment evidence, and the complexity of the registration process for inclusion in the Australian Register of Therapeutic Goods (ARTG).
The classification is determined by the device's:
- Intended Use.
- Level of Invasiveness.
- Duration of Use.
- Dependence on an energy source.
TGA Device Classification and Risk Levels
| Device Class | Risk Level | Description & Examples |
|---|---|---|
| Class I | Low Risk | Typically non-invasive and do not sustain or support life. Most Class I devices can be self-assessed. Examples include bandages, examination gloves, and tongue depressors. |
| Class IIa | Low to Moderate Risk | Devices presenting a low to moderate risk, often involving short-term invasive use. Examples include dental fillings, hearing aids, and contact lenses. |
| Class IIb | Moderate to High Risk | Devices associated with moderate to high risk, potentially involving long-term use or significant invasiveness. Examples include infusion pumps, ventilators, and bone fixation plates. |
| Class III | High Risk | Devices that pose the highest risk, are often life-sustaining or life-supporting, or are permanently implanted. Examples include heart valves, pacemakers, and deep brain stimulators. |
| AIMD | Highest Risk | Active Implantable Medical Devices, such as implantable pacemakers or defibrillators, are subject to the strictest controls. |
In Vitro Diagnostic Devices (IVDs)
IVDs are classified separately, also based on risk, for their use in examining samples from the human body for diagnostic information. Examples include blood glucose meters, pregnancy tests, and Polymerase Chain Reaction (PCR) test kits.
Regulatory Impact of Classification
The assigned classification directly influences the manufacturer's obligations:
- Conformity Assessment: Higher-risk classes (IIb, III, AIMD) require more extensive evidence of compliance with the Essential Principles (the TGA's safety and performance requirements). For Class IIb and Class III, this often involves a mandatory TGA application audit.
- Quality Management System (QMS): All manufacturers must implement and maintain a QMS compliant with ISO 13485:2016 standards.
- Registration Pathway:
- Standard Class I: Most can be included in the ARTG with minimal documentation.
- Special Class I (Sterile or Measuring Function): These devices require additional conformity assessment documentation despite their low-risk classification.
- Class IIa, IIb, III, AIMD: Require formal Conformity Assessment Certificates (often relying on international approvals like EU or FDA) and a full registration submission by an Australian Sponsor.
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Australian Medical Device Registration: The Role of the Sponsor and TGA Inclusion
Medical device registration in Australia with the TGA requires an **Australian Sponsor** to facilitate market access. Registration involves demonstrating compliance with the **Essential Principles** through conformity assessment evidence (e.g., EU Notified Body certificates, FDA approvals). Products are listed on the **ARTG**, with higher-risk devices (Class III/AIMD) subject to mandatory **Level 2 audits**.
Approximately 5 minutes
Australia Medical Device Labeling: TGA Compliance and Sponsor Requirements
Australian medical device labeling must adhere to the **TGA's Therapeutic Goods (Medical Devices) Regulations 2002**. The **Australian Sponsor's** name and address must appear on the outer packaging. Required information includes the device's intended use, manufacturer details, mandatory warnings, and full traceability data (batch/lot/serial number, and expiration date if applicable) to ensure safety and compliance with the Essential Principles.
Approximately 5 minutes
Australia Medical Device License Maintenance: Annual Charges and ARTG Variations
Maintaining medical device market access in Australia requires payment of mandatory **Annual Charges** to the TGA every August and submitting a **Variation to an ARTG inclusion entry** for any modifications. The Australian Sponsor is responsible for managing these obligations, which include updating **Manufacturer's Evidence** (e.g., renewed certificates, address changes) to prevent license revocation or suspension.
Approximately 5 minutes
Post-Market Surveillance: Sponsor's Role in TGA Vigilance
Post-Market Surveillance (PMS) in Australia is mandatory, with the **Australian Sponsor** being responsible for reporting all **Australian adverse incidents** and **overseas regulatory actions** to the TGA. For high-risk devices (AIMD, Class III, implantable Class IIb), the Sponsor must submit **three consecutive annual reports** detailing product complaints. The TGA uses these reports to initiate potential recalls, hazard alerts, or product modifications.